A new meta-analysis of ECMO in cardiogenic shock and arrest showed an impressive 30-day survival rate of over 30% but at the cost of significant levels of complications (neurological/infective/renal). A couple of months ago CHEER trial team published their results with a protocol that reads like science-fiction for many of us: A senior team leader, …
Tracman said no, but others have shown benefit. Siempos’ meta-analysis of 13 trials suggests thinking again. Depending on which statistical model you use, it appears that early tracheostomy may reduce 30 day mortality, particularly, or exclusively in patients with high baseline risk of death. Less pneumonia and, unsurprisingly, shorter ICU stay is also suggested. However longer …
LITFL Wessex ICS BottomLine Emcrit
Which co-morbidities really matter (at least in Scotland!)?
July 30, 2014
For over 1000 Scottish teaching hospital admissions, using univariate logistic regression: IHD, ALD, COPD, obesity, rheumatological disease, functional status and, just barely, age all impact upon unit or hospital death. Surprisingly many conditions such as DM, malignancy, tromboembolic disease, CVA and several others did not.